These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 26003640

  • 21. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
    Liu Y, Ouyang B, Chen J, Chen M, Ma J, Wu J, Huang S, Li L, Liu Z, Guan X.
    Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H.
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [Abstract] [Full Text] [Related]

  • 25. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
    Tan HK, Baldwin I, Bellomo R.
    Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Circuit life span of continuous renal replacement therapy in critically ill patients with or without conventional anticoa-gulation: an observational prospective study].
    Sanz M, Hidalgo F, García-Fernández N.
    An Sist Sanit Navar; 2017 Apr 30; 40(1):77-84. PubMed ID: 28534557
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacokinetics of meropenem administered with prolonged infusion time in patients receiving continuous veno-venous hemofiltration].
    Bo SN, Li HL, Zhu X, Yao GQ, Hu YF, Zhai SD, Lu W, Wang SY, Xu YZ, He B.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Mar 30; 24(3):145-8. PubMed ID: 22401158
    [Abstract] [Full Text] [Related]

  • 34. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
    Villa G, Di Maggio P, De Gaudio AR, Novelli A, Antoniotti R, Fiaccadori E, Adembri C.
    Crit Care; 2016 Nov 19; 20(1):374. PubMed ID: 27863531
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Nov 19; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Continuous veno-venous hemofiltration in treatment of acute severe hyponatremia: a report of 6 cases].
    Ji DX, Gong DH, Xu B, Tao J, Ren B, Zhang YD, Liu Y, Hu WX, Li LS.
    Zhonghua Nei Ke Za Zhi; 2003 Nov 19; 42(11):781-4. PubMed ID: 14636466
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.